Harikrishnan et al. used siRNA to knock down FBLN1C and FBLN1D expression in NSCLC Calu-1 cells to examine if FBLN1 isoforms could play a role in controlling EGFR signaling and function (28). Here, EGFR is linked to non-small cell lung carcinoma.